Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

M16-106 adult and pediatric ALL clinical trial - RNAseq dataset

ABSTRACT: M16-106 adult and pediatric ALL clinical trial - RNAseq dataset

PROVIDER: PRJNA683653 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

M16-106 adult and pediatric ALL clinical trial - RNAseq dataset

Project description:Combining venetoclax, a selective BCL-2 inhibitor, with low-dose navitoclax, a BCL-XL/BCL-2 inhibitor, may potentiate therapeutic BCL-2 and BCL XL inhibition without dose-limiting thrombocytopenia associated with navitoclax monotherapy. The safety and preliminary efficacy of venetoclax with low-dose navitoclax and chemotherapy was assessed in this phase 1 dose escalation study (NCT03181126) in pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma. Forty-seven patients received treatment. A recommended phase 2 dose of 50 mg navitoclax for adults and 25 mg for patients <45 kg with 400 mg adult-equivalent venetoclax was identified. Delayed hematopoietic recovery was the primary safety finding. The complete remission rate was 60%, including responses in patients who had previously received hematopoietic cell transplantation or immunotherapy. Thirteen (28%) patients proceeded to transplantation or CAR T-cell therapy on study. Venetoclax with navitoclax and chemotherapy was well tolerated and had promising efficacy in this heavily pretreated patient population.

2021-02-17 | GSE162894 | GEO

GOYA DLBCL clinical trial - RNASeq dataset

Project description:This dataset contains collected RNASeq data of 552 samples from the GOYA clinical trial.

2019-02-01 | GSE125966 | GEO

GOYA DLBCL clinical trial - RNASeq dataset

Project description:GOYA DLBCL clinical trial - RNASeq dataset

| PRJNA518119 | ENA

Trial

Project description:Trial Trial

| PRJEB7892 | ENA

Expression data from 36 KRAS-mutant lung adenocarcinomas from the BATTLE-2 clinical trial.

Project description:In this dataset, we include expression data from 36 KRAS-mutant lung adenocarcinomas from Stage 1 of the BATTLE-2 trial, reflecting patients whose disease has relapsed or progresses following at least one front-line metastatic chemotherapy regimen. Tumor biopsy was performed following informed consent and prior to randomisation to one of the four possible treatment arms.

2015-10-01 | GSE61913 | GEO

Clinical Trial Sequencing Project (CTSP)

Project description:Clinical Trial Sequencing Project (CTSP)

| PRJNA331220 | ENA

FOCUS clinical trial

Project description:Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

| PRJEB20349 | ENA

Gene expression profiling of newly diagnosed multiple myeloma patients included in the HOVON95 clinical trial

Project description:This gene expression set contains data from patients included in the HOVON95 clinical trial. Using this data the relation between a signature identifying patients with aggressive biology and clinical parameters was studied in newly diagnosed multiple myeloma patients. This dataset was used to identify the relationship between a signature for aggressive disease and clinical parameters.

2022-06-01 | GSE164706 | GEO

Firmicutes bacterium JGI 0000112-M16

Project description:Firmicutes bacterium JGI 0000112-M16

| PRJNA176567 | ENA